KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CRISPR Therapeutics AG (CRSP) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for CRISPR Therapeutics AG (CRSP) over the last 10 years, with Q4 2025 value amounting to 0.0.

  • CRISPR Therapeutics AG's Asset Utilization Ratio fell 9061.92% to 0.0 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.0, marking a year-over-year decrease of 9061.92%. This contributed to the annual value of 0.0 for FY2025, which is 9066.78% down from last year.
  • As of Q4 2025, CRISPR Therapeutics AG's Asset Utilization Ratio stood at 0.0, which was down 9061.92% from 0.02 recorded in Q3 2025.
  • CRISPR Therapeutics AG's 5-year Asset Utilization Ratio high stood at 0.37 for Q2 2021, and its period low was 0.0 during Q4 2022.
  • In the last 5 years, CRISPR Therapeutics AG's Asset Utilization Ratio had a median value of 0.06 in 2023 and averaged 0.11.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 7554113.33% in 2021, then plummeted by 9984.12% in 2022.
  • Quarter analysis of 5 years shows CRISPR Therapeutics AG's Asset Utilization Ratio stood at 0.33 in 2021, then plummeted by 99.84% to 0.0 in 2022, then skyrocketed by 32895.55% to 0.17 in 2023, then crashed by 90.35% to 0.02 in 2024, then plummeted by 90.62% to 0.0 in 2025.
  • Its last three reported values are 0.0 in Q4 2025, 0.02 for Q3 2025, and 0.02 during Q2 2025.